Intero Biosystems ships lab-grown mini human intestines for drug testing

1 reports1 report sources3 days agoUpdate

Get up to speed on this story

AI Summary

Denver-based Intero Biosystems is now selling GastroScreen, a lab-grown human intestinal organoid about one millimeter across, intended for use in drug testing. The model is a human intestinal organoid, meaning it is grown from human cells rather than animal tissue, which the company positions as a way for drug developers to test candidates against human gut biology.

AI-generated from reports · 3 days agoUpdate

Latest updatesOct 15 07:00

Intero Biosystems ships lab-grown mini human intestines for drug testing

Report timeline

Follow the reports to understand different sides of the story.

Oct 15

07:00
TechCrunch Startups
Intero Biosystems ships lab-grown mini human intestines for drug testing
Denver-based Intero Biosystems sells GastroScreen, a human intestinal organoid model about one millimeter across.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

Midu WeeklyMondays · funding trends and top roundsSee a sample issue →SF WeeklyFridays · San Francisco startups, rounds and eventsSee a sample issue →

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing